查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1473853

全球系统性曲菌症/系统性念珠菌症市场（2024 年版）：按类型、治疗方法、最终用户、地区和国家、市场洞察和预测进行分析（2020-2030 年）

Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition): Analysis By Type (Candidiasis, Aspergillosis), By Treatment Approach, By End User, By Region, By Country: Market Insights and Forecast (2020-2030)
出版日期: | 出版商: Azoth Analytics | 英文 250 Pages | 订单完成后即时交付

价格

2020-2023年，全球系统性曲菌症/系统性念珠菌症市场规模复合年增长率为3.62%。

2023年市场规模为71.8亿美元，预计2030年将达96.2亿美元。可支配收入水准的上升，尤其是富人的可支配收入水准的上升，正在推动对优质抗老化手术和护肤产品的需求。

曲菌症和念珠菌症是世界上最常见的真菌感染疾病，常见于免疫力较弱的人，例如移植受者、接受化疗的癌症患者以及爱滋病毒/爱滋病感染者。这些感染疾病可表现为严重的感染疾病、感染疾病或侵袭性性行为感染，如果不及时诊断和治疗，会导致严重的发病率和死亡率。

系统性曲菌症/系统性念珠菌症的治疗以抗真菌药物为主，其中Azole、棘白菌素类和Polyenes是主要的治疗选择。如果标准治疗无效或出现抗药性，这些药物也可以一起使用。在某些情况下，例如侵袭性肺部曲菌症或真菌性心内膜炎，可能需要手术作为辅助性治疗。

由于真菌感染疾病的增加、诊断方法的改进、医疗保健专业人员和人们意识的提高以及抗真菌治疗的扩大，市场正在获得动力。此外，人口老化、免疫抑制治疗和医院感染等因素也在推动市场扩张。

该市场的特点是来自製药公司和医疗机构等主要企业的激烈竞争。这些公司不断创新并推出新产品和解决方案，以满足医疗保健提供者、实验室和患者不断变化的需求。

该报告研究了全球系统性曲菌症/系统性念珠菌症市场，并提供包括市场规模和预测、区域和細項分析以及主要趋势和机会在内的资讯。

目录

第一章 市集背景

  • 产品范围和产品前景
  • 执行摘要
  • 调查方法

第二章 分析师建议

  • 个人化医疗
  • 拓展新兴市场

第三章全球系统性曲菌症/系统性念珠菌症市场：表现与预测

  • 宏观经济因素对全球系统性曲菌症/系统性念珠菌症市场的影响分析
  • 常见致命真菌感染疾病的年发生率
  • 系统性曲菌症/系统性念珠菌症的抗真菌治疗正在开发中
  • 全球系统性曲菌症/系统性念珠菌症市场：仪表板
  • 全球系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
  • 全球系统性曲菌症/系统性念珠菌症市场：市场金额评估
  • 评估 COVID-19 对全球系统性曲菌症/系统性念珠菌症市场的影响
  • 全球系统性曲菌症/系统性念珠菌症市场细分：按类型
    • 全球系统性曲菌症/系统性念珠菌症市场：按类型、概述
    • 全球系统性曲菌症/系统性念珠菌症市场吸引力指数：按类型
    • 全球系统性曲菌症/系统性念珠菌症市场规模：念珠菌症（金额）（2020-2030）
    • 全球系统性曲菌症/系统性念珠菌症市场规模：曲菌症（金额）（2020-2030）
  • 全球系统性曲菌症/系统性念珠菌症市场细分：依治疗方法
    • 全球系统性曲菌症/系统性念珠菌症市场：依治疗方法分类，概述
    • 全球系统性曲菌症/系统性念珠菌症市场吸引力指数：依治疗方法
    • 全球系统性曲菌症/系统性念珠菌症市场规模：抗真菌药物（金额）（2020-2030）
    • 全球系统性曲菌症/系统性念珠菌症市场规模：联合治疗（金额）（2020-2030）
    • 全球系统性曲菌症/系统性念珠菌症市场规模：手术（金额）（2020-2030）
  • 全球系统性曲菌症/系统性念珠菌症市场细分：按最终用户分类
    • 全球系统性曲菌症/系统性念珠菌症市场概述：按最终用户分类
    • 全球系统性曲菌症/系统性念珠菌症市场吸引力指数：依最终用户分类
    • 全球系统性曲菌症/系统性念珠菌症市场规模：医院（金额）（2020-2030）
    • 全球系统性曲菌症/系统性念珠菌症市场规模：诊所（金额）（2020-2030）
    • 全球系统性曲菌症/系统性念珠菌症市场规模：其他最终用户（金额）（2020-2030）

第四章全球系统性曲菌症/系统性念珠菌症市场，区域分析

  • 研究的区域范围
  • 区域简介

第五章美洲系统性曲菌症/系统性念珠菌症市场：表现与预测

  • 美洲系统性曲菌症/系统性念珠菌症市场：简介
  • 美洲系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
  • 美洲系统性曲菌症/系统性念珠菌症市场：主要驱动因素
  • 美洲系统性曲菌症/系统性念珠菌症市场：細項分析
  • 美洲系统性曲菌症/系统性念珠菌症市场细分：按类型
  • 美洲系统性曲菌症/系统性念珠菌症市场细分：依治疗方法
  • 按最终用户分類的美洲系统性曲菌症/系统性念珠菌症市场细分
  • 按国家/地区分類的美洲系统性曲菌症/系统性念珠菌症市场细分
    • 美洲系统性曲菌症/系统性念珠菌症市场：按国家/地区划分，概述
    • 美国系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
    • 加拿大系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
    • 其他美洲系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）

第六章欧洲系统性曲菌症/系统性念珠菌症市场：表现与预测

  • 欧洲系统性曲菌症/系统性念珠菌症市场：简介
  • 欧洲系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
  • 欧洲系统性曲菌症/系统性念珠菌症市场：主要驱动因素
  • 欧洲系统性曲菌症/系统性念珠菌症市场：細項分析
  • 欧洲系统性曲菌症/系统性念珠菌症市场细分：按类型
  • 欧洲系统性曲菌症/系统性念珠菌症市场细分：依治疗方法
  • 欧洲系统性曲菌症/系统性念珠菌症市场细分：按最终用户
  • 欧洲系统性曲菌症/系统性念珠菌症市场细分：按国家/地区
    • 欧洲系统性曲菌症/系统性念珠菌症市场：按国家/地区划分，概述
    • 德国系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
    • 英国系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
    • 法国系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
    • 义大利系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
    • 西班牙系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
    • 其他欧洲系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）

第七章亚太地区系统性曲菌症/系统性念珠菌症市场：实际与预测

  • 亚太地区系统性曲菌症/系统性念珠菌症市场：概况
  • 亚太地区系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
  • 亚太地区系统性曲菌症/系统性念珠菌症市场：主要驱动因素
  • 亚太地区系统性曲菌症/系统性念珠菌症市场：細項分析
  • 亚太地区系统性曲菌症/系统性念珠菌症市场细分：按类型
  • 亚太地区系统性曲菌症/系统性念珠菌症市场区隔：依治疗方法
  • 亚太地区系统性曲菌症/系统性念珠菌症市场细分：依最终用户分类
  • 亚太地区系统性曲菌症/系统性念珠菌症市场细分：按国家/地区
    • 亚太地区系统性曲菌症/系统性念珠菌症市场：按国家/地区划分，概述
    • 中国系统性曲菌症/系统性念珠菌症市场：市场规模及复合年增长率（2020-2030）
    • 日本系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
    • 印度系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
    • 其他亚太地区系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）

第 8 章中东和非洲系统性曲菌症/系统性念珠菌症市场：表现和预测

  • 中东和非洲系统性曲菌症/系统性念珠菌症市场：简介
  • 中东和非洲系统性曲菌症/系统性念珠菌症市场：市场规模和复合年增长率（2020-2030）
  • 中东和非洲系统性曲菌症/系统性念珠菌症市场：主要驱动因素
  • 中东和非洲系统性曲菌症/系统性念珠菌症市场：細項分析
  • 中东和非洲系统性曲菌症/系统性念珠菌症市场细分：按类型
  • 中东和非洲系统性曲菌症/系统性念珠菌症市场细分：按治疗方法
  • 中东和非洲系统性曲菌症/系统性念珠菌症最终用户市场细分

第九章市场动态

  • 评估市场动态对系统性曲菌症/系统性念珠菌症市场的影响
  • 促进因素
  • 抑制因素
  • 趋势

第10章产业生态系分析

  • 波特分析

第十一章竞争定位

  • 企业产品定位
  • 市场地位矩阵
  • 系统性曲菌症/系统性念珠菌症市场市场占有率分析
  • 公司简介
    • Sanofi
    • Cipla
    • Pfizer
    • GSK PLC
    • Novartis AG
    • Bayer AG
    • Merck & Co., Inc.
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Gilead Sciences, Inc.

第十二章 关于我们公司、免责声明

Executive Summary

Azoth Analytics has released a research report titled "Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition)" which provides a complete analysis of the Global Systemic Aspergillosis and Systemic Candidiasis industry in terms of market segmentation By Type (Candidiasis, Aspergillosis), By Treatment Approach (Antifungal Medications, Combination Therapy, and Surgical Intervention) By End Users (Hospitals, Clinics, Other End-users) for the historical period of 2020-2023, the estimates of 2024 and the forecast period of 2025-2030.

The report analyses the Global Systemic Aspergillosis and Systemic Candidiasis Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada, Germany, United Kingdom, France, Italy, Spain, China, Japan, India). The Global Systemic Aspergillosis and Systemic Candidiasis market showcased growth at a CAGR of 3.62% during 2020-2023.

The market was valued at USD 7.18 Billion in 2023 which is expected to reach USD 9.62 Billion in 2030. Growing disposable income levels, particularly among affluent consumers, have fuelled demand for premium anti-aging Surgical Intervention and skincare products.

Aspergillosis and candidiasis are among the most common fungal infections worldwide, affecting individuals with compromised immune systems, such as transplant recipients, cancer patients

undergoing chemotherapy, and those with HIV/AIDS. These infections can manifest as severe pulmonary, bloodstream, or invasive infections, leading to substantial morbidity and mortality if not promptly diagnosed and treated.

Antifungal drugs continue to serve as the foundation for treating systemic aspergillosis and systemic candidiasis, with azoles, echinocandins, and polyenes representing the primary

treatment options. Combinations of these medications may be utilized in cases where standard therapy proves ineffective or to combat instances of emerging drug resistance. In certain

scenarios, such as invasive pulmonary aspergillosis or fungal endocarditis, surgical procedures may be warranted as adjunctive therapy.

The Global Systemic Aspergillosis and Systemic Candidiasis Market experiences momentum due to rising occurrences of fungal infections, improved diagnostic methods, heightened awareness among healthcare practitioners and individuals, and the expanding array of antifungal treatments. Furthermore, factors such as population aging, immunosuppressive treatments, and hospital- acquired transmissions bolster the market's expansion.

The market is characterized by intense competition among key players, including pharmaceutical companies, and healthcare organizations. These companies are continuously innovating and launching new products and solutions to meet the evolving needs of healthcare providers, laboratories, and patients.

Scope of the Report:

  • The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market by Value (USD Billion).
  • The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market by Region (Americas, Europe, Asia Pacific, Middle East & Africa) and 10 Countries (United States, Canada,

Germany, United Kingdom, France, Italy, Spain, China, Japan, India).

  • The report presents the analysis of Systemic Aspergillosis and Systemic Candidiasis Market for the historical period of 2020-2023, the estimated year 2024 and the forecast period of 2025-2030.
  • The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By Type (Candidiasis, Aspergillosis)
  • The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By Treatment Approach (Antifungal Medications, Combination Therapy, and Surgical Intervention).
  • The report analyses the Systemic Aspergillosis and Systemic Candidiasis Market By End Users (Hospitals, Clinics, and Other End Users).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By Type, By Treatment Approach and By End User.
  • Also, the major opportunities, trends, drivers, and challenges of the industry has been analyzed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Sanofi, Cipla, Pfizer, GSK PLC, Novartis AG, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche AG, Abbott Laboratories and Gilead Sciences, Inc.

Table of Contents

Table of Content

1. Market Background

  • 1.1 Scope and Product Outlook
  • 1.2 Executive Summary
  • 1.3 Research Methodology

2. Analyst Recommendations

  • 2.1 Personalized Medicine
  • 2.2 Penetrating Developing Markets

3. Global Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

  • 3.1 Impact Analysis of Macro Economic Factors on Global Systemic Aspergillosis and Systemic Candidiasis Market
  • 3.2 Annual incidence of commoner life-threatening fungal infections
  • 3.3 Antifungal Therapies for Systemic Aspergillosis And Systemic Candidiasis in Pipeline
  • 3.4 Global Systemic Aspergillosis and Systemic Candidiasis Market: Dashboard
  • 3.5 Global Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 3.6 Global Systemic Aspergillosis and Systemic Candidiasis Market: Market Value Assessment
  • 3.7 Assessment Degree of Impact of COVID-19 on Global Systemic Aspergillosis and Systemic Candidiasis Market
  • 3.8 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
    • 3.8.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
    • 3.8.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By Type
    • 3.8.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.8.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.9 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
    • 3.9.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
    • 3.9.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By Treatment Approach
    • 3.9.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.9.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.9.5 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
  • 3.10 Global Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
    • 3.10.1 Global Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
    • 3.10.2 Global Systemic Aspergillosis and Systemic Candidiasis Market Attractiveness Index, By End-users
    • 3.10.3 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.10.4 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
    • 3.10.5 Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

4. Global Systemic Aspergillosis and Systemic Candidiasis Market, Region Analysis

  • 4.1 Regional Coverage of the Study
  • 4.2 Regional Snapshot

5. Americas Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

  • 5.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
  • 5.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 5.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
  • 5.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
  • 5.5 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
    • 5.5.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
    • 5.5.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.5.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.6 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: Treatment Approach
    • 5.6.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
    • 5.6.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.6.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.7 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
    • 5.7.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
    • 5.7.2 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.7.3 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
    • 5.7.4 Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
  • 5.8 Americas Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
    • 5.8.1 Americas Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
    • 5.8.2 United States Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.8.2.1 United States Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 5.8.2.2 United States Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 5.8.2.3 United States Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 5.8.3 Canada Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.8.3.1 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 5.8.3.2 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 5.8.3.3 Canada Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 5.8.4 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 5.8.4.1 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 5.8.4.2 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 5.8.4.3 Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

6. Europe Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

  • 6.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
  • 6.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
  • 6.4 Europe Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
  • 6.5 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
    • 6.5.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
    • 6.5.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.5.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.6 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
    • 6.6.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
    • 6.6.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.6.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.7 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
    • 6.7.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
    • 6.7.2 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.7.3 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
    • 6.7.4 Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
  • 6.8 Europe Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
    • 6.8.1 Europe Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
    • 6.8.2 Germany Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.2.1 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.2.2 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.2.3 Germany Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 6.8.3 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.3.1 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.3.2 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.3.3 United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 6.8.4 France Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.4.1 France Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.4.2 France Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.4.3 France Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 6.8.5 Italy Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.5.1 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.5.2 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.5.3 Italy Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 6.8.6 Spain Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.6.1 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.6.2 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.6.3 Spain Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 6.8.7 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 6.8.7.1 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 6.8.7.2 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 6.8.7.3 Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

7. Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

  • 7.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
  • 7.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 7.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
  • 7.4 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
  • 7.5 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
    • 7.5.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
    • 7.5.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.5.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.6 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
    • 7.6.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
    • 7.6.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.6.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.7 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
    • 7.7.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
    • 7.7.2 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.7.3 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
    • 7.7.4 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)
  • 7.8 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Country
    • 7.8.1 Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, by Country Overview
    • 7.8.2 China Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.2.1 China Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 7.8.2.2 China Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 7.8.2.3 China Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 7.8.3 Japan Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.3.1 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 7.8.3.2 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 7.8.3.3 Japan Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 7.8.4 India Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.4.1 India Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 7.8.4.2 India Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 7.8.4.3 India Systemic Aspergillosis and Systemic Candidiasis Market, By End-users
    • 7.8.5 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
      • 7.8.5.1 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type
      • 7.8.5.2 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach
      • 7.8.5.3 Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users

8. Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Historic and Forecast

  • 8.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Snapshot
  • 8.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Market Size and CAGR, 2020-2030 (USD Billion & CAGR)
  • 8.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Key Factors
  • 8.4 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market: Segment Analysis
  • 8.5 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Type
    • 8.5.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Type Overview
    • 8.5.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.5.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.6 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By Treatment Approach
    • 8.6.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach Overview
    • 8.6.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.6.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billion & CAGR)
  • 8.7 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Segmentation: By End-users
    • 8.7.1 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By End-users Overview
    • 8.7.2 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.7.3 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billion & CAGR)
    • 8.7.4 Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billion & CAGR)

9. Market Dynamics

  • 9.1 Impact assessment of Market Dynamics on Systemic Aspergillosis and Systemic Candidiasis Market
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Trends

10. Industry Ecosystem Analysis

  • 10.1 Porter Analysis

11. Competitive Positioning

  • 11.1 Companies' Product Positioning
  • 11.2 Market Position Matrix
  • 11.3 Market Share Analysis of Systemic Aspergillosis and Systemic Candidiasis Market
  • 11.4 Company Profiles
    • 11.4.1 Sanofi
    • 11.4.2 Cipla
    • 11.4.3 Pfizer
    • 11.4.4 GSK PLC
    • 11.4.5 Novartis AG
    • 11.4.6 Bayer AG
    • 11.4.7 Merck & Co., Inc.
    • 11.4.8 F. Hoffmann-La Roche AG
    • 11.4.9 Abbott Laboratories
    • 11.4.10 Gilead Sciences, Inc.

12. About Us & Disclaimer

List of Figures

List of Figures

  • Figure 1: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020-2023 (USD Billion)
  • Figure 2: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2024-2030 (USD Billion)
  • Figure 3: Global Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
  • Figure 4: Market Attractiveness Analysis of Global Systemic Aspergillosis and Systemic Candidiasis Market, By Type (2025-2030)
  • Figure 5: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 6: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Candidiasis, 2020-2030 (USD Billion)
  • Figure 7: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 8: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Aspergillosis, 2020-2030 (USD Billion)
  • Figure 9: Market Attractiveness Analysis of Global Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach (2025-2030)
  • Figure 10: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 11: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Antifungal Medications, 2020-2030 (USD Billion)
  • Figure 12: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 13: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Combination Therapy, 2020-2030 (USD Billion)
  • Figure 14: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 15: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Surgical Intervention, 2020-2030 (USD Billion)
  • Figure 16: Market Attractiveness Analysis of Global Systemic Aspergillosis and Systemic Candidiasis Market, By End-users (2025-2030)
  • Figure 17: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 18: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Hospitals, 2020-2030 (USD Billion)
  • Figure 19: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 20: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Clinics, 2020-2030 (USD Billion)
  • Figure 21: Global Systemic Aspergillosis and Systemic Candidiasis Market Size, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 22: Global Systemic Aspergillosis and Systemic Candidiasis Market Absolute Opportunity, By Other End-users, 2020-2030 (USD Billion)
  • Figure 23: Americas Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 24: Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
  • Figure 25: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 26: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 27: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 28: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 29: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 30: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 31: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 32: Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 33: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 34: United States Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 35: United States Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 36: United States Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 37: United States Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 38: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 39: Canada Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 40: Canada Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 41: Canada Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 42: Canada Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 43: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 44: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 45: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 46: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 47: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 48: Europe Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 49: Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
  • Figure 50: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 51: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 52: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 53: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 54: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 55: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 56: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 57: Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 58: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 59: Germany Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 60: Germany Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 61: Germany Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 62: Germany Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 63: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 64: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 65: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 66: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 67: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 68: France Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 69: France Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 70: France Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 71: France Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 72: France Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 73: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 74: Italy Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 75: Italy Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 76: Italy Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 77: Italy Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 78: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 79: Spain Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 80: Spain Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 81: Spain Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 82: Spain Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 83: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 84: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 85: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 86: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 87: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 88: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 89: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
  • Figure 90: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 91: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 92: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 93: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 94: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 95: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 96: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 97: Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 98: China Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 99: China Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 100: China Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 101: China Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 102: China Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 103: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 104: Japan Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 105: Japan Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 106: Japan Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 107: Japan Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 108: India Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 109: India Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 110: India Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 111: India Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 112: India Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 113: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Value, 2020-2030 (USD Billions & CAGR)
  • Figure 114: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Value, By Treatment Approach, 2023 (USD Billion)
  • Figure 115: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By Type, By Value, 2023 (%)
  • Figure 116: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By Treatment Approach, By Value, 2023 (%)
  • Figure 117: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, By Value, 2023 (%)
  • Figure 118: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Size, By Value, 2020H-2030F (USD Billion)
  • Figure 119: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market Share, By End-users, 2023 (%)
  • Figure 120: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Candidiasis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 121: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Aspergillosis, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 122: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Antifungal Medications, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 123: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Combination Therapy, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 124: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Surgical Intervention, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 125: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Hospitals, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 126: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Clinics, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 127: Middle East and Africa Systemic Aspergillosis and Systemic Candidiasis Market, By Other End-users, By Value, 2020H-2030F (USD Billions & CAGR)
  • Figure 128: Market Share of Prominent Companies of Systemic Aspergillosis and Systemic Candidiasis Market, 2023 (%)
  • Figure 129: Sanofi Revenues, 2020-2022 (USD Million)
  • Figure 130: Sanofi Revenues, By Geographic Segments, 2022 (%)
  • Figure 131: Sanofi Revenue , By Business Segments, 2022 (%)
  • Figure 132: Cipla Revenues, 2020-2022 (USD Million)
  • Figure 133: Cipla Revenues, By Geographic Segments, 2022 (%)
  • Figure 134: Pfizer Revenues, 2020-2022 (USD Million)
  • Figure 135: Pfizer Revenues, By Business Segments, 2023 (%)
  • Figure 136: Pfizer Inc. Revenue , By Geographical Segments, 2023 (%)
  • Figure 137: GSK PLC Revenue, 2020-2022 (USD Million)
  • Figure 138: GSK PLC Revenue , By Business Segments, 2022 (%)
  • Figure 139: GSK PLC Revenue, By Geography Segment, 2022 (%)
  • Figure 140: Novartis Revenue, 2020-2022 (USD Million)
  • Figure 141: Novartis Revenue, By Business Segments, 2022 (%)
  • Figure 142: Novartis Revenue, By Geographical Segments, 2022 (%)
  • Figure 143: Bayer AG Revenues, 2020-2022 (USD Million)
  • Figure 144: Bayer AG Revenues, By Geographic Segments, 2022 (%)
  • Figure 145: Bayer AG Revenues, By Business Segments, 2022 (%)
  • Figure 146: Merck & Co., Inc. Revenues, 2020-2022 (USD Million)
  • Figure 147: Merck & Co., Inc. Revenues, By Geographic Segments, 2022 (%)
  • Figure 148: Merck & Co., Inc. Revenue , By Business Segments, 2022 (%)
  • Figure 149: Roche Revenues, 2021-2023 (USD Million)
  • Figure 150: Roche Revenue , By Sales Division, 2023 (%)
  • Figure 151: Roche Revenue , By Geographical Segment, 2023 (%)
  • Figure 152: Abbott Laboratories Revenues, 2021-2023 (USD Million)
  • Figure 153: Abbott Laboratories Revenues, By Geographic Segments, 2023 (%)
  • Figure 154: Abbott Laboratories Revenue , By Business Segments, 2023 (%)
  • Figure 155: Gilead Sciences, Inc. Revenues, 2021-2023 (USD Million)
  • Figure 156: Gilead Sciences, Inc. Revenues, By Geographic Segments, 2023 (%)
  • Figure 157: Gilead Sciences, Inc. Revenue , By Therapeutic Area, 2023 (%)

List of Tables

Table A1: Global Impact of Macro Economic Factors, By Region

Table A2: Annual incidence of commoner life-threatening fungal infections

Table A3: Antifungal Therapies for Systemic Aspergillosis And Systemic Candidiasis in Pipeline

Table A4: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A5: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A6: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A7: United States Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A8: United States Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A9: United States Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A10: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A11: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A12: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A13: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A14: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A15: Canada Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A16: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A17: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A18: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A19: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A20: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A21: Rest of Americas Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A22: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A23: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A24: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A25: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A26: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A27: Germany Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A28: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A29: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A30: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A31: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A32: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A33: United Kingdom Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A34: France Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A35: France Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A36: France Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A37: France Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A38: France Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A39: France Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A40: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A41: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A42: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A43: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A44: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A45: Italy Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A46: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A47: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A48: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A49: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A50: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A51: Spain Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A52: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A53: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A54: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A55: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A56: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A57: Rest of Europe Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A58: China Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A59: China Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A60: China Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A61: China Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A62: China Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A63: China Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A64: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A65: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A66: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A67: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A68: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A69: Japan Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A70: India Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A71: India Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A72: India Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A73: India Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A74: India Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A75: India Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A76: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2020-2023 (USD Billion)

Table A77: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Type, By Value, 2025-2030 (USD Billion)

Table A78: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2020-2023 (USD Billion)

Table A79: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By Treatment Approach, By Value, 2025-2030 (USD Billion)

Table A80: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2020-2023 (USD Billion)

Table A81: Rest of Asia Pacific Systemic Aspergillosis and Systemic Candidiasis Market, By End-users, By Value, 2025-2030 (USD Billion)

Table A82: Sanofi Key Financials, 2020-2022

Table A83: Cipla Key Financials, 2020-2022

Table A84: Pfizer Key Financials, 2021-2023

Table A85: GSK PLC Key Company Financials, 2020-2022

Table A86: Novartis Key Company Financials, 2020-2022

Table A87: Bayer AG Key Financials, 2020-2022

Table A88: Merck & Co., Inc. Key Financials, 2020-2022

Table A89: Roche Key Financials, 2021-2023

Table A90: Abbott Laboratories Key Financials, 2021-2023

Table A91: Gilead Sciences, Inc. Key Financials, 2021-2023